N4 Pharma PLC Holding(s) in Company (1427G)
25 May 2017 - 12:15AM
UK Regulatory
TIDMN4P
RNS Number : 1427G
N4 Pharma PLC
24 May 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or N4 Pharma Plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------- ------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
--------------------------------------------------------------- --------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
--------------------------------------------------------------- --------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
--------------------------------------------------------------- --------------
An event changing the breakdown of voting rights
--------------------------------------------------------------- --------------
Other (please
specify):
---------------------------------------------------------- --- --------------
3. Full name of person(s) Peel Hunt LLP
subject to the
notification obligation:
(iii)
----------------------------------------------------------- ------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
----------------------------------------------------------- ------------------
5. Date of the transaction 22/05/2017
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- ------------------
6. Date on which issuer 24/05/2017
notified:
----------------------------------------------------------- ------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 10%
----------------------------------------------------------- ------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- ---------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- --------------- --------------- -------------- -------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ----------- ----------- -------------- ------------ ------------ ------------ -----------
Under Under
Ordinary 10% 10% 7,200,622 7,200,622 10.04%
--------------- --------------- -------------- ------------ ------------ ------------ -----------
GB00BYW8QM32
------------- ----------- ----------- ------------ ---------- ------------ -------- ---------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------- ------------------------------- ---------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- ------------- ------------- ---------------- ---------------------------- -----------------------
Nominal Delta
--------------- ------------- ------------- ---------------- ---------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- -------------------------------------------------------------------
7,200,622 10.04%
------------------------------------------------- -------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------------------
Proxy Voting:
-----------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- --------------
11. Number of voting rights proxy
holder will cease to hold:
------------------------------------------------------------- --------------
12. Date on which proxy holder will
cease to hold voting rights:
------------------------------------------------------------- --------------
13. Additional information:
------------------------------------------------------------- --------------
14. Contact name: Paul Crispin
------------------------------------------------------------- --------------
15. Contact telephone number: 0207 418 8988
------------------------------------------------------------- --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFISEFISFID
(END) Dow Jones Newswires
May 24, 2017 10:15 ET (14:15 GMT)
N4 Pharma (LSE:N4P)
Historical Stock Chart
From May 2024 to Jun 2024
N4 Pharma (LSE:N4P)
Historical Stock Chart
From Jun 2023 to Jun 2024